Catharine Wolfe, MD
Psychiatry · Marietta, GANPI 1346530359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $474 and has fallen 91.1% since, to $42 in 2025.
Across 107 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$425
- Takeda Pharmaceuticals U.S.A., Inc.$339
- Teva Pharmaceuticals USA, Inc.$261
- Johnson & Johnson$144
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$109
- Eisai Inc.$93
- plus $488 from 13 others
What the payments were for
- Food & beverage$1,859100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $425 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $339 |
| Teva Pharmaceuticals USA, Inc. | 15 | $261 |
| Johnson & Johnson | 8 | $144 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $109 |
| Eisai Inc. | 6 | $93 |
| Otsuka America Pharmaceutical, Inc. | 6 | $90 |
| Neurocrine Biosciences, Inc. | 4 | $71 |
| Corium, LLC | 3 | $63 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Shire North American Group Inc | 2 | $34 |
| Noven Therapeutics, LLC | 2 | $28 |
| Adlon Therapeutics L.p. | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
How this compares
$1,859 in reported general payments places this provider in the 75th percentile of 900 psychiatry providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 26 | $8,531 |
| Aripiprazole | 57 | $6,704 |
| Lisdexamfetamine Dimesylate | 25 | $4,682 |
| Fluvoxamine Maleate | 36 | $2,922 |
| Clorazepate Dipotassium | 12 | $2,675 |
| Clozapine | 34 | $2,264 |
| Bupropion XlBupropion Hcl | 91 | $1,894 |
| Duloxetine Hcl | 87 | $1,846 |
| Eszopiclone | 22 | $1,545 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 27 | $1,450 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 46 | $1,341 |
| Fluoxetine Hcl | 95 | $1,245 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 53 | $1,147 |
| Escitalopram Oxalate | 57 | $1,124 |
| Clonazepam | 139 | $1,004 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Marietta
- Michael BanovMarietta$733K
- Michael UngerMarietta$35K
- Amy HollandMarietta$17K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.